The Asia-Pacific anti-inflammatory therapeutics market is expected to grow at a CAGR of 8.6% over the forecast period, owing to the rising healthcare expenditure, disposable income of individuals, increasing popularity of biologics and better healthcare access. Increase in the number of autoimmune and respiratory diseases, new drugs in development pipeline and increased usage of OTC NSAIDs are the major factors driving the Asia-Pacific anti-inflammatory market. Moreover, increasing awareness of anti-inflammatory biologics and favorable government initiatives in the Asia-Pacific region are expected to drive the market during the analysis period. Factors, such as side effects of anti-inflammatory drugs and uncertain patent legislations, i.e., compulsory licensing in India would continue to impede the market growth.
The Asia-Pacific anti-inflammatory therapeutics market is segmented on the basis of indication, drug class and geography. The indications considered in this report include arthritis, respiratory diseases, multiple sclerosis, psoriasis, inflammatory bowel disease and other inflammatory diseases. Among indications, arthritis was the dominant segment accounting for 41.3% of the APAC anti-inflammatory therapeutics market in 2014 and holds potential for growth during the forecast period. Anti-inflammatory biologics are the most preferred drugs for treatment of arthritis.
On the basis of drug class, the market is segmented into anti-inflammatory biologics, non-steroidal anti-inflammatory drugs (NSAIDs) and corticosteroids. Anti-inflammatory biologics holds the largest share among drug classes accounting for around 50% share of the Asia-Pacific anti-inflammatory therapeutics market, and is expected to grow rapidly during the forecast period. Geographically, the market is segmented into six countries namely Japan, China, India, Australia, South Korea, Indonesia and others. Among these countries, Japan holds the largest share in the Asia-Pacific anti-inflammatory therapeutics market; however, China is expected to exhibit the fastest growth during the forecast period. Major market players have adopted strategies such as collaborations, indication expansions and product launches to expand their market presence. In 2014, Novartis got marketing approval for the drug Cosentyx (secukinumab) in Japan for the treatment of psoriatic arthritis. The company has filed new patents to overcome the issues of patent expiries of their existing drugs and to gain a prominent market share. The key companies profiled in this report are Pfizer, Inc., AbbVie, Inc., Johnson & Johnson, GlaxoSmithKline plc, Merck & CO., Inc., Novartis AG, F. Hoffmann-La Roche AG, Eli Lily and Company, AstraZeneca PLC and Amgen.
KEY MARKET BENEFITS
KEY MARKET SEGMENTS
The Asia-Pacific Anti-inflammatory Therapeutics Market is segmented below:
SIMILAR MARKET STUDIES
Notes: Sales, means the sales volume of Neonatal Noninvasive Ventilator Revenue, means the sales value of Neonatal Noninvasive Ventilator This report studies sales (consumption) of Neonatal Noninvasive Ventilator in Europe market, especially in Germany, France, UK, Russia, Italy, Spain and Benelux, focuses on top players in these countries, with sales, price, revenue and ...
January 2017 | $3900 | View Details >>
DelveInsight “Gastric Cancer - Epidemiology Forecast To 2023” provides an overview of the epidemiology trends of Gastric Cancer in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical and forecasted data of Gastric Cancer prevalent or incident cases segmented by age, sex ...
February 2017 | $2750 | View Details >>
The industry report package Insulin Markets in the Top 5 Asian Countries to 2019 - Market Size, Development, and Forecasts offers the most up-to-date market data on the actual market situation, and future outlook for insulin in the top 5 Asian countries. The package includes insulin country reports from the ...
August 2015 | $2349 | View Details >>
Notes: Production, means the output of Orthopedic Biomaterial Revenue, means the sales value of Orthopedic Biomaterial This report studies Orthopedic Biomaterial in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering ...
December 2016 | $2900 | View Details >>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research